Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 8/20 | 0.58 |
| ▸ | MMP9 | P14780 | 8/20 | 0.58 |
| ▸ | MMP13 | P45452 | 8/20 | 0.58 |
| ▸ | MMP7 | P09237 | 6/20 | 0.58 |
| ▸ | ADAM17 | P78536 | 3/20 | 0.58 |
| ▸ | ADAM10 | O14672 | 1/20 | 0.58 |
| ▸ | MMP8 | P22894 | 1/20 | 0.58 |
| ▸ | MMP14 | P50281 | 1/20 | 0.58 |
| ▸ | MMP2 | P08253 | 5/20 | 0.52 |
| ▸ | MMP3 | P08254 | 5/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14025835 | 1.00 | MMP1 (0.58) | MMP1MMP9MMP13MMP7ADAM17 | |
| SCHEMBL14045788 | 0.83 | NPSR1 (0.48) | MMP1MMP9MMP13MMP7ADAM17 | |
| SCHEMBL4916984 | 0.82 | MMP9 (0.60) | MMP1MMP9MMP13MMP7ADAM17 | |
| SCHEMBL14025839 | 0.82 | MMP9 (0.60) | MMP1MMP9MMP13MMP7ADAM17 | |
| SCHEMBL8108645 | 0.81 | MMP1 (0.70) | MMP1MMP9MMP13MMP7ADAM17 | |
| SCHEMBL26757902 | 0.81 | MMP1 (0.73) | MMP1MMP9MMP13MMP7ADAM17 | |
| SCHEMBL4925180 | 0.80 | MMP9 (0.52) | MMP1MMP9MMP13MMP7ADAM17 | |
| SCHEMBL14025834 | 0.80 | MMP9 (0.52) | MMP1MMP9MMP13MMP7ADAM17 | |
| SCHEMBL13185380 | 0.80 | ADAMTS4 (0.69) | MMP1MMP9MMP13MMP7MMP8 | |
| SCHEMBL5094030 | 0.80 | MMP1 (0.56) | MMP1MMP9MMP13MMP7ADAM17 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080269282-A1 | Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof | GENMEDICA THERAPEUTICS SL (ES) | 2008-10-30 | — | — | US | claimed |
| JP-2008508348-A | — | — | 2008-03-21 | — | — | JP | claimed |
| EP-1796681-A2 | COMPOUNDS FOR INHIBITING COPPER-CONTAINING AMINE OXIDASES AND USES THEREOF | Genmedica Therapeutics SL (ES) | 2007-06-20 | — | — | EP | claimed |
| US-20070066646-A1 | Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof | GENMEDICA THERAPEUTICS SL (ES) | 2007-03-22 | — | — | US | claimed |
| WO-2006013209-A2 | COMPOUNDS FOR INHIBITING COPPER-CONTAINING AMINE OXIDASES AND USES THEREOF | GENMEDICA THERAPEUTICS SL (ES) | 2006-02-09 | — | — | WO | claimed |
| US-20070066646-A1 | Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof | GENMEDICA THERAPEUTICS SL (ES) | 2007-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080269282-A1 | Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof | AOC2, AOC3, AOC1 | MMP1 387/4885MMP9 856/4885MMP13 781/4885 |
| US-20070066646-A1 | Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof | AOC2, AOC3, AOC1 | MMP1 510/4885MMP9 1037/4885MMP13 898/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.